John Brodersen
Cited by
Cited by
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
Z Saghir, A Dirksen, H Ashraf, KS Bach, J Brodersen, PF Clementsen, ...
Thorax 67 (4), 296-301, 2012
The Danish randomized lung cancer CT screening trial—overall design and results of the prevalence round
JH Pedersen, H Ashraf, A Dirksen, K Bach, H Hansen, P Toennesen, ...
Journal of Thoracic Oncology 4 (5), 608-614, 2009
Long-term psychosocial consequences of false-positive screening mammography
J Brodersen, VD Siersma
The Annals of Family Medicine 11 (2), 106-115, 2013
Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling
MMW Wille, A Dirksen, H Ashraf, Z Saghir, KS Bach, J Brodersen, ...
American journal of respiratory and critical care medicine 193 (5), 542-551, 2016
Breast screening: the facts—or maybe not
PC Gøtzsche, OJ Hartling, M Nielsen, J Brodersen, KJ Jørgensen
Bmj 338, 2009
Overdiagnosis: what it is and what it isn’t
J Brodersen, LM Schwartz, C Heneghan, JW O’Sullivan, JK Aronson, ...
BMJ Evidence-Based Medicine 23 (1), 1-3, 2018
Quantification of harms in cancer screening trials: literature review
B Heleno, MF Thomsen, DS Rodrigues, KJ Jørgensen, J Brodersen
Bmj 347, 2013
Walking the tightrope: communicating overdiagnosis in modern healthcare
KJ McCaffery, J Jansen, LD Scherer, H Thornton, J Hersch, SM Carter, ...
Bmj 352, 2016
Quaternary prevention: reviewing the concept: Quaternary prevention aims to protect patients from medical harm
C Martins, M Godycki-Cwirko, B Heleno, J Brodersen
European Journal of General Practice 24 (1), 106-111, 2018
To nudge or not to nudge: cancer screening programmes and the limits of libertarian paternalism
T Ploug, S Holm, J Brodersen
J Epidemiol Community Health 66 (12), 1193-1196, 2012
The adequacy of measurement of short and long-term consequences of false-positive screening mammography
J Brodersen, H Thorsen, J Cockburn
Journal of Medical Screening 11 (1), 39-44, 2004
Participation bias in a randomised trial of screening for lung cancer
MS Hestbech, V Siersma, A Dirksen, JH Pedersen, J Brodersen
Lung Cancer 73 (3), 325-331, 2011
Rasch analysis of the Knee injury and Osteoarthritis Outcome Score (KOOS): a statistical re‐evaluation
J Comins, J Brodersen, M Krogsgaard, N Beyer
Scandinavian journal of medicine & science in sports 18 (3), 336-345, 2008
Methodological aspects of differential item functioning in the Rasch model
J Brodersen, D Meads, S Kreiner, H Thorsen, L Doward, S McKenna
Journal of Medical Economics 10 (3), 309-324, 2007
The benefits and harms of screening for cancer with a focus on breast screening
J Brodersen, KJ Jorgensen, PC Gotzsche
Pol Arch Med Wewn 120 (3), 89-94, 2010
Overdiagnosis: how cancer screening can turn indolent pathology into illness
J Brodersen, LM Schwartz, S Woloshin
Apmis 122 (8), 683-689, 2014
Validation of a condition-specific measure for women having an abnormal screening mammography
J Brodersen, H Thorsen, S Kreiner
Value in health 10 (4), 294-304, 2007
Informed choice requires information about both benefits and harms
KJ Jørgensen, J Brodersen, OJ Hartling, M Nielsen, PC Gøtzsche
Journal of medical ethics 35 (4), 268-269, 2009
Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire
J Brodersen, H Thorsen
Scandinavian journal of primary health care 26 (4), 251-256, 2008
Measuring the psychosocial consequences of screening
J Brodersen, SP McKenna, LC Doward, H Thorsen
Health and Quality of life outcomes 5 (1), 1-4, 2007
The system can't perform the operation now. Try again later.
Articles 1–20